S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   3,380.35 (+1.40%)
DOW   27,976.84 (+1.05%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:PLXPPLx Pharma Stock Price, Forecast & News

$3.42
+0.21 (+6.54 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.27
Now: $3.42
$3.60
50-Day Range
$2.83
MA: $3.04
$3.41
52-Week Range
$1.80
Now: $3.42
$6.53
Volume22,400 shs
Average Volume10,866 shs
Market Capitalization$31.31 million
P/E RatioN/A
Dividend YieldN/A
Beta4.16
PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing its PLxGuard delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce acute gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention. Its product pipeline also includes other oral non-steroidal anti-inflammatory drugs using the PLxGuard delivery system, such as PL1200 Ibuprofen 200 mg, a GI-safer ibuprofen product for pain and inflammation, as well as PL1100 Ibuprofen 400 mg. The company was founded in 2002 and is headquartered in Houston, Texas.
Read More
PLx Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.55 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PLXP
CUSIPN/A
Phone973-409-6541

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$570,000.00
Book Value($1.32) per share

Profitability

Net Income$-20,500,000.00
Net Margins-3,369.72%

Miscellaneous

Employees12
Market Cap$31.31 million
Next Earnings Date8/14/2020 (Confirmed)
OptionableNot Optionable
$3.42
+0.21 (+6.54 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PLXP News and Ratings via Email

Sign-up to receive the latest news and ratings for PLXP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PLx Pharma (NASDAQ:PLXP) Frequently Asked Questions

How has PLx Pharma's stock been impacted by Coronavirus?

PLx Pharma's stock was trading at $4.81 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PLXP shares have decreased by 28.9% and is now trading at $3.42.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of PLx Pharma?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PLx Pharma in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PLx Pharma
.

When is PLx Pharma's next earnings date?

PLx Pharma is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020.
View our earnings forecast for PLx Pharma
.

How can I listen to PLx Pharma's earnings call?

PLx Pharma will be holding an earnings conference call on Friday, August 14th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were PLx Pharma's earnings last quarter?

PLx Pharma Inc (NASDAQ:PLXP) issued its earnings results on Friday, May, 15th. The biotechnology company reported ($0.37) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.40) by $0.03.
View PLx Pharma's earnings history
.

Has PLx Pharma been receiving favorable news coverage?

News articles about PLXP stock have been trending somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. PLx Pharma earned a media sentiment score of -1.2 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term.
View the latest news about PLx Pharma
.

Are investors shorting PLx Pharma?

PLx Pharma saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 167,300 shares, a decrease of 11.2% from the December 15th total of 188,400 shares. Based on an average daily trading volume, of 10,500 shares, the days-to-cover ratio is presently 15.9 days.
View PLx Pharma's Short Interest
.

Who are some of PLx Pharma's key competitors?

What other stocks do shareholders of PLx Pharma own?

Who are PLx Pharma's key executives?

PLx Pharma's management team includes the following people:
  • Mr. Michael J. Valentino, Exec. Chairman (Age 65)
  • Ms. Natasha Giordano, CEO, Pres & Director (Age 59)
  • Mr. Gary L. Mossman, Sr. Advisor (Age 78)
  • Mr. Ronald R. Zimmerman, Founder & Sr. Advisor (Age 66)
  • Ms. Rita M. O'Connor CPA, Chief Financial Officer (Age 51)

When did PLx Pharma IPO?

(PLXP) raised $68 million in an initial public offering on Thursday, February 4th 2016. The company issued 3,800,000 shares at $17.00-$19.00 per share. Raymond James served as the underwriter for the IPO and Maxim Group LLC and Janney Montgomery Scott were co-managers.

What is PLx Pharma's stock symbol?

PLx Pharma trades on the NASDAQ under the ticker symbol "PLXP."

How do I buy shares of PLx Pharma?

Shares of PLXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is PLx Pharma's stock price today?

One share of PLXP stock can currently be purchased for approximately $3.42.

How big of a company is PLx Pharma?

PLx Pharma has a market capitalization of $31.31 million and generates $570,000.00 in revenue each year. The biotechnology company earns $-20,500,000.00 in net income (profit) each year or ($4.74) on an earnings per share basis. PLx Pharma employs 12 workers across the globe.

What is PLx Pharma's official website?

The official website for PLx Pharma is www.plxpharma.com.

How can I contact PLx Pharma?

PLx Pharma's mailing address is 9 Fishers Lane Suite E, Sparta NJ, 07871. The biotechnology company can be reached via phone at 973-409-6541 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.